Literature DB >> 1352719

Influence of anaesthesia on the cardiovascular effects of rilmenidine and clonidine in spontaneously hypertensive rats.

F Sannajust1, C Cerutti, E Koenig-Bérard, J Sassard.   

Abstract

1. The acute cardiovascular effects of two alpha 2-adrenoceptor agonists, rilmenidine and clonidine, were studied in 15-week-old male spontaneously hypertensive rats (SHRs). The effects of these drugs were compared with intravenous (i.v.) and intracerebroventricular (i.c.v.) administration in conscious and pentobarbitone-anaesthetized SHRs, in which aortic blood pressure (BP) was continuously recorded. 2. In conscious SHRs, i.v. doses of either rilmenidine (30, 100, 300 micrograms kg-1) or clonidine (3, 10, 30 micrograms kg-1) induced dose-dependent short-lasting increases in BP followed by moderate decreases associated with bradycardia, while the same three doses of both drugs given i.c.v. were devoid of BP and heart rate (HR) effects. 3. Pentobarbitone-anaesthesia increased the sympathetic control of BP and suppressed the cardiac baroreflex sensitivity. 4. In anaesthetized SHRs, i.v. injections of the same 3 doses of rilmenidine and clonidine induced a slight increase in BP, rapidly followed by profound and long-lasting BP and HR decreases. Surprisingly, when given i.c.v., these 3 doses lowered BP and HR to the same extent but in a more progressive manner. 5. The lack of efficacy of both drugs in conscious SHRs after the i.c.v. administration of i.v. active doses and the lack of more marked and rapid effects in anaesthetized SHRs, after i.c.v. than after i.v. injections, question the involvement of a major central site of action for these antihypertensive alpha 2-adrenoceptor agonists. Moreover, these results show that the cardiovascular effects of these drugs are profoundly influenced by baseline sympathetic nervous system activity which is enhanced by pentobarbitone-anaesthesia.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1352719      PMCID: PMC1908436          DOI: 10.1111/j.1476-5381.1992.tb09016.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  31 in total

1.  Localization in the CNA of adrenoceptors which facilitate a cardioinhibitory reflex.

Authors:  W Kobinger; L Pichler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

2.  Anesthetic effects on tonic and reflex renal sympathetic nerve activity in awake cats.

Authors:  K Matsukawa; I Ninomiya
Journal:  Am J Physiol       Date:  1989-02

3.  Pharmacological characterization of alpha adrenoceptors involved in the antinociceptive and cardiovascular effects of intrathecally administered clonidine.

Authors:  R E Solomon; M J Brody; G F Gebhart
Journal:  J Pharmacol Exp Ther       Date:  1989-10       Impact factor: 4.030

4.  Cardiovascular effects of rilmenidine, a new alpha 2-adrenoceptor agonist, and clonidine in conscious spontaneously hypertensive rats.

Authors:  F Sannajust; C Julien; C Barrès; C Cerutti; E Koenig-Bérard; J Sassard
Journal:  Clin Exp Pharmacol Physiol       Date:  1989-11       Impact factor: 2.557

5.  Pharmacology of the alpha 2-adrenoceptor agonist rilmenidine.

Authors:  P A Van Zwieten
Journal:  Am J Cardiol       Date:  1988-02-24       Impact factor: 2.778

6.  A multicenter double-blind comparative study of rilmenidine and clonidine in 333 hypertensive patients.

Authors:  J P Fillastre; B Letac; F Galinier; G Le Bihan; J Schwartz
Journal:  Am J Cardiol       Date:  1988-02-24       Impact factor: 2.778

7.  Differences in the ability of yohimbine to antagonize the hypotensive effect of clonidine in normotensive and spontaneously hypertensive anesthetized rats.

Authors:  E Tibirica; J Feldman; P Bousquet
Journal:  J Pharmacol Exp Ther       Date:  1988-03       Impact factor: 4.030

8.  Postsynaptic spinal alpha-adrenoceptors mediate effects of intrathecal clonidine.

Authors:  H E Connor; L Finch
Journal:  Eur J Pharmacol       Date:  1981-11-19       Impact factor: 4.432

9.  Role of imidazole receptors in the vasodepressor response to clonidine analogs in the rostral ventrolateral medulla.

Authors:  P Ernsberger; R Giuliano; R N Willette; D J Reis
Journal:  J Pharmacol Exp Ther       Date:  1990-04       Impact factor: 4.030

10.  Central and peripheral effects of S 3341 [(N-dicyclopropylmethyl)-amino-2-oxazoline] in animal models.

Authors:  P A van Zwieten; M J Thoolen; F A Jonkman; B Wilffert; A de Jonge; P B Timmermans
Journal:  Arch Int Pharmacodyn Ther       Date:  1986-01
View more
  3 in total

1.  Sympathoinhibitory effects of rilmenidine may be mediated by sites located below the brainstem.

Authors:  F Sannajust; C Barrès; E Koenig-Bérard; J Sassard
Journal:  Br J Pharmacol       Date:  1992-03       Impact factor: 8.739

2.  Brainstem adenosine A1 receptor signaling masks phosphorylated extracellular signal-regulated kinase 1/2-dependent hypotensive action of clonidine in conscious normotensive rats.

Authors:  Noha Nassar; Abdel A Abdel-Rahman
Journal:  J Pharmacol Exp Ther       Date:  2008-10-10       Impact factor: 4.030

3.  Sympathoinhibition by rilmenidine in conscious rabbits: involvement of alpha 2-adrenoceptors.

Authors:  B Szabo; R Urban; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-12       Impact factor: 3.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.